Earnings reaction · LRCX

How analysts reacted to Lam Research’s results

Lam Research reported on July 29, 2026 (quarter ended Jun 2026). In the next sessions, 4 Wall Street firms published notes: 4 cut their price target. The median target of the 4 firms with a before-and-after figure went from $402 to $359 (−11%). The shares rose 18% on Jul 30, the first session after the report.

Jul 29, 2026 reported4 firms0 raised4 cut
Median target$402 → $359−11% · 4 firms
Target changes0 raised4 cut · 0 kept
Share move+18%Jul 30 · $252.35 → $297.72
EPS vs consensusBeat 8%1.82 vs 1.69 expected

Every firm’s call 4

The first note from each firm in the session that reacted to the results and the next two, with its previous target. Since then the shares have gained 11% ($329.51 on Oct 7), against a median target of $359 from these firms. Lam Research consensus today

Before After Share price
MizuhoBuy$400$370−8%Jul 30
B RileyBuy$385$350−9%Jul 30
Morgan StanleyBuy$404$367−9%Jul 30
Wells FargoBuy$450$350−22%Jul 30

Earlier Lam Research reports

Latest earnings reactions

All earnings reactions

How this works: the earnings date and EPS figures come from Nasdaq. The calls are the notes in our database from the session that reacted to the results and the next two, one per firm (its first); for reports after the close, notes dated the report day are treated as previews and left out. “Before” is the previous target quoted in the note or, if missing, the firm’s last target in our database. The median target uses firms with both figures. The share move compares the close before the reaction session with the close of the session that moved most (the report day or the next one). Which firms’ targets come true

Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.